lysyl-aspartyl-glutamyl-leucine has been researched along with Glioma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batra, SK; Bigner, DD; Lorimer, IA; Pastan, I; Wikstrand, CJ | 1 |
1 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and Glioma
Article | Year |
---|---|
Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors.
Topics: 3T3 Cells; Animals; Antibodies, Monoclonal; Breast Neoplasms; Cell Survival; Drug Design; ErbB Receptors; Female; Glioma; Humans; Immunotoxins; Lung Neoplasms; Mice; Mutagenesis, Site-Directed; Oligopeptides; Protein Sorting Signals; Recombinant Proteins; Sequence Deletion; Transfection | 1995 |